Aclaris Therapeutics, Inc. Quarterly Return On Equity in % from Q2 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2016 to Q3 2024.
  • Aclaris Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -26.3 %, a 59.3% increase year-over-year.
  • Aclaris Therapeutics, Inc. annual Return On Equity for 2023 was -52.8 %, a 26.6% decline from 2022.
  • Aclaris Therapeutics, Inc. annual Return On Equity for 2022 was -41.7 %, a 12.8% increase from 2021.
  • Aclaris Therapeutics, Inc. annual Return On Equity for 2021 was -47.8 %, a 56.4% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -26.3 +38.3 +59.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -39.8 +14.6 +26.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -48.7 -2.25 -4.85% Jan 1, 2024 Mar 31, 2024
Q4 2023 -52.8 -11.1 -26.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -64.5 -25.1 -63.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -54.4 -14.3 -35.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -46.4 -7.31 -18.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -41.7 +6.11 +12.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -39.4 +14.7 +27.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -40.1 +26.5 +39.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -39.1 +67.9 +63.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -47.8 +61.9 +56.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -54.1 +49.3 +47.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -66.7 +87.3 +56.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -107 +52.1 +32.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -110 +26.2 +19.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -103 +13.5 +11.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -154 -60.7 -65.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -159 -81 -104% Jan 1, 2020 Mar 31, 2020
Q4 2019 -136 -63.8 -88.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -117 -54.2 -86.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -93.2 -44.6 -91.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -78.1 -36.9 -89.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -72.1 -37.8 -110% Oct 1, 2018 Dec 31, 2018
Q3 2018 -62.8 -32 -104% Jul 1, 2018 Sep 30, 2018
Q2 2018 -48.6 -14.4 -41.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -41.1 -3.14 -8.27% Jan 1, 2018 Mar 31, 2018
Q4 2017 -34.4 +11 +24.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 -30.8 +16.9 +35.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -34.2 +38.2 +52.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -38 Jan 1, 2017 Mar 31, 2017
Q4 2016 -45.4 Oct 1, 2016 Dec 31, 2016
Q3 2016 -47.6 Jul 1, 2016 Sep 30, 2016
Q2 2016 -72.4 Apr 1, 2016 Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.